Here you can find up to date and historic QRCC news articles (Newest to Oldest).
QRCC Sponsor Oversight Virtual Seminar
by Katie Tam | April 16, 2024 | News | 0 Comments
We are pleased to announce that registration is now open for the virtual QRCC seminar titled “Sponsor Oversight of Outsourced Clinical Trials”. This seminar (a virtual version of the in-person Sponsor Oversight seminar held last year), will focus on the Sponsor...
QRCC 2024 Easter Opening Hours
QRCC attending EUCROF24 congress
by Alex Gage | January 31, 2024 | News | 0 Comments
Alex Gage, QRCC's Director & Head of Clinical Operations, will be attending the EUCROF24 congress in Prague on the 19th and 20th February. Alex is looking forward to connecting with colleagues across Europe and talking about how QRCC can help companies with their...
QRCC Sponsor Oversight Virtual Seminar
by Alex Gage | December 21, 2023 | News, Uncategorized | 0 Comments
Following on from the success of our in-person Sponsor Oversight seminar held at the end of November, we are happy to announce that we will be holding a virtual version of the seminar in Q1 2024 to allow our colleagues and clients based further afield and ex-UK to...
QRCC Seminar 30th November 2023
QRCC Seminar 30th November 2023
by Alex Gage | October 17, 2023 | News | 0 Comments
We are pleased to announce that registration is now open for the first QRCC seminar since COVID-19, titled “Sponsor Oversight of Outsourced Clinical Trials”. This seminar will focus on the Sponsor oversight responsibilities as set out in the draft of ICH E6 R3 (the...
Veeva Summit R&D and Quality
QRCC Easter Opening Hours
Conference Attendance
by Alex Gage | February 22, 2023 | News | 0 Comments
QRCC will be attending several conferences in 2023 including the OBN Biotrinity meeting in London in April and the One Nucleus On Helix congress in Cambridge in July. We look forward to meeting with clients and colleagues and hearing about the latest hot topics and...
Happy New Year!
Christmas Opening hours
by Katie Tam | December 2, 2022 | Information | 0 Comments
QRCC would like to thank our clients and collaborators for their continued support in 2022 and to wish you all every success with the fresh opportunities that 2023 may bring. QRCC will close for Christmas on 23 December 2022 and will re-open 03 January 2023.
QRCC are Hiring!
QRCC is 10 years old!
by Alex Gage | April 4, 2022 | News | 0 Comments
We are delighted to report that QRCC reached a significant milestone on the 2nd April 2022 by celebrating 10 years in business! Since commencing trading back in 2012 we have grown steadily to support our expanding portfolio of clients and now employ 18 staff across...
QRCC welcome two new members of staff
QRCC’s Director and Head of Clinical Operations, Alex Gage, is appointed joint Chair of the CCRA’s Regulatory Affairs Working Group
by admin | February 23, 2021 | Uncategorized | 0 Comments
The CCRA (Clinical & Contract Research Association) Regulatory Affairs Working Group was established early in 2021 with an initial mandate to support its members’ interests as follows: To keep a watching brief on the status of the current UK Government Trade...
QRCC upcoming meeting attendance
by admin | February 17, 2021 | Information | 0 Comments
QRC Consultants will be attending the following Industry events: The ICR Ethics & GCP Forum, March 18th, 2021 (Online) OBN BioLearn, March 24th, 2021 (Online) European QA Symposium, May 20-21, 2021 (Online) You are welcome to introduce yourself to us at any of...
Current working arrangements
by admin | January 6, 2021 | Archive | 0 Comments
Following the Government announcement of a third National Lockdown QRCC has taken appropriate measures to ensure that it can continue to operate as usual in supporting its customers during the current pandemic. We have implemented some logistical changes in line with...
QRCC complete Management Buy Out
by admin | December 16, 2020 | News | 0 Comments
QRCC is pleased to announce the successful completion of a Management Buy Out, effective 28 October 2020, such that Sarah Nicholson, Director and Head of Regulatory and Alex Gage, Director and Head of Clinical Operations are now majority shareholders. Sarah Fryer...